Aios Medical

Aios Medical discovered genuine demand through waitlist conversion rates exceeding 40% when they launched early access to ClinicOS, their AI-powered clinical operating system for GLP-1 prescriptions. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌Rather than relying on survey responses about interest in weight management, they measured actual behavior: patients completing full medical intake forms, scheduling consultations, and proceeding through verification steps. Within the first three months, they tracked that users who engaged with their AI-guided assessment tool showed 3x higher completion rates than traditional clinic intake processes, indicating the friction they were solving mattered deeply. Revenue traction proved demand most convincingly—customers paid upfront for consultations despite GLP-1 being available through other channels, suggesting Aios's convenience premium resonated. The team also observed that repeat prescription refills through their platform exceeded 65%, demonstrating that initial interest translated into sustained usage rather than one-time curiosity. These behavioral metrics—conversion velocity, completion rates, and retention—validated that accessibility barriers were the real problem worth solving.